IT1258182B - COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI - Google Patents

COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI

Info

Publication number
IT1258182B
IT1258182B ITFI920167A ITFI920167A IT1258182B IT 1258182 B IT1258182 B IT 1258182B IT FI920167 A ITFI920167 A IT FI920167A IT FI920167 A ITFI920167 A IT FI920167A IT 1258182 B IT1258182 B IT 1258182B
Authority
IT
Italy
Prior art keywords
vacuolization
compositions containing
helicobacter pylori
bafilomycina
inhibition induced
Prior art date
Application number
ITFI920167A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITFI920167A priority Critical patent/IT1258182B/en
Publication of ITFI920167A0 publication Critical patent/ITFI920167A0/en
Priority to CA002142313A priority patent/CA2142313A1/en
Priority to AU47095/93A priority patent/AU4709593A/en
Priority to JP6505871A priority patent/JPH08502725A/en
Priority to PCT/EP1993/002149 priority patent/WO1994004161A1/en
Priority to EP93917786A priority patent/EP0654999A1/en
Publication of ITFI920167A1 publication Critical patent/ITFI920167A1/en
Application granted granted Critical
Publication of IT1258182B publication Critical patent/IT1258182B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Sono descritte composizioni contenenti bafilomycina capaci di inibire la vacuolizzazione cellulare indotto da Helicobacter pylori.Compositions containing bafilomycin capable of inhibiting Helicobacter pylori-induced cell vacuolization are described.

ITFI920167A 1992-08-12 1992-08-12 COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI IT1258182B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI920167A IT1258182B (en) 1992-08-12 1992-08-12 COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI
CA002142313A CA2142313A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h atpases
AU47095/93A AU4709593A (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type H+ atpases
JP6505871A JPH08502725A (en) 1992-08-12 1993-08-11 Use of Vacuolar H +++ ATPase inhibitors
PCT/EP1993/002149 WO1994004161A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h+ atpases
EP93917786A EP0654999A1 (en) 1992-08-12 1993-08-11 Use of inhibitors of vacuolar-type h?+ atpases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920167A IT1258182B (en) 1992-08-12 1992-08-12 COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI

Publications (3)

Publication Number Publication Date
ITFI920167A0 ITFI920167A0 (en) 1992-08-12
ITFI920167A1 ITFI920167A1 (en) 1994-02-12
IT1258182B true IT1258182B (en) 1996-02-20

Family

ID=11350200

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI920167A IT1258182B (en) 1992-08-12 1992-08-12 COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI

Country Status (6)

Country Link
EP (1) EP0654999A1 (en)
JP (1) JPH08502725A (en)
AU (1) AU4709593A (en)
CA (1) CA2142313A1 (en)
IT (1) IT1258182B (en)
WO (1) WO1994004161A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
DE4442970A1 (en) * 1994-12-02 1996-06-05 Byk Gulden Lomberg Chem Fab Model for screening cpds. for inhibition of Helicobacter
US5981184A (en) * 1994-12-02 1999-11-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Screening kit and process for determining action of substances inhibiting the P-type ATPase activity of Helicobacter pylori
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
WO2020149295A1 (en) * 2019-01-18 2020-07-23 国立研究開発法人科学技術振興機構 V-atpase activity inhibitor, antibacterial agent, medicine, antibacterial method and screening method

Also Published As

Publication number Publication date
WO1994004161A1 (en) 1994-03-03
JPH08502725A (en) 1996-03-26
ITFI920167A0 (en) 1992-08-12
ITFI920167A1 (en) 1994-02-12
EP0654999A1 (en) 1995-05-31
CA2142313A1 (en) 1994-03-03
AU4709593A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
DE69408460D1 (en) HIGHLY PURE FLUORELASTOMER COMPOSITIONS
GR1002038B (en) Laparascopic instrument for the application of endoligatures.
HU9302762D0 (en) N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors
IL129768A0 (en) Antithrombotic organic nitrates
SG65581A1 (en) Pharmaceutical compositions containing cyclosporins
DE69413237D1 (en) Plättchenaggregationsinhibitoren
ITTO920847A1 (en) "FLOATING COMPENSATOR FOR PALOMBARI".
DK537389A (en) THE GLYCOSIDASE INHIBITOR SALBOSTATIN, ITS PREPARATION AND USE
PL330908A1 (en) Inhibitors of prenyl transferases
JO1704B1 (en) New active compounds
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
PH31395A (en) Bis-naphthalimides for the treatment of cancer.
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
IT1258182B (en) COMPOSITIONS CONTAINING BAFILOMYCINA FOR THE VACUOLIZATION INHIBITION INDUCED BY HELICOBACTER PYLORI
HU9400726D0 (en) Film-forming compositions containing iodo-phenoxy-alkylen-ether derivatives for visualizing the gastrointes tinal tract
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
EP0707640A4 (en) (1 $m(7) 3, 1 $m(7) 4)-$g(b)-GLUCANASE OF ENHANCED STABILITY
ITTO910541A0 (en) WATERPROOFING COATING, PARTICULARLY FOR THE ELIMINATION OF LEAKAGES
TR27833A (en) "Pour-on" formulation for the application of anthelmintics.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
IL98405A0 (en) Pharmaceutical compositions containing enzyme inhibiting agents
ZA927393B (en) Regioselective synthesis of 1,5-diarylpyrazole anti-inflammatory agents
AU2267992A (en) Compounds used for the inhibition of hiv-protease
GB2283677B (en) Liquid anthelmintic selenium compositions
NO914123L (en) PROCEDURE FOR CORROSION PROTECTION OF J-ROES

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970827